Cargando…

Impact of Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging—What Do We Know So Far? (A Narrative Review)

Vascular aging, early vascular aging or supernormal vascular aging are concepts used for estimating the cardiovascular risk at a certain age. From the famous line of Thomas Sydenham that “a man is as old as his arteries” to the present day, clinical studies in the field of molecular biology of the v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adam, Cristina Andreea, Anghel, Razvan, Marcu, Dragos Traian Marius, Mitu, Ovidiu, Roca, Mihai, Mitu, Florin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224553/ https://www.ncbi.nlm.nih.gov/pubmed/35743834 http://dx.doi.org/10.3390/life12060803

Ejemplares similares

Cardiac Rehabilitation in Peripheral Artery Disease in a Tertiary Center—Impact on Arterial Stiffness and Functional Status after 6 Months
por: Anghel, Razvan, et al.
Publicado: (2022)

Cardiac Rehabilitation in Patients with Peripheral Artery Disease—A Literature Review in COVID-19 Era
por: Anghel, Razvan, et al.
Publicado: (2022)

Cardiac Rehabilitation and Mortality Risk Reduction in Peripheral Artery Disease at 6-Month Outcome
por: Anghel, Razvan, et al.
Publicado: (2022)

Subendocardial Viability Ratio Predictive Value for Cardiovascular Risk in Hypertensive Patients
por: Aursulesei Onofrei, Viviana, et al.
Publicado: (2022)

Mortality Risk Assessment in Peripheral Arterial Disease—The Burden of Cardiovascular Risk Factors over the Years: A Single Center’s Experience
por: Aursulesei Onofrei, Viviana, et al.
Publicado: (2022)

Arterial Stiffness Assessment Using the Arteriograph in Patients with Moderate–Severe OSA and Metabolic Syndrome—A Pilot Study
por: Zota, Ioana Mădălina, et al.
Publicado: (2021)

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
por: Andreea, Munteanu Madalina, et al.
Publicado: (2023)

CPAP Influence on Readily Available Inflammatory Markers in OSA—A Pilot Study
por: Zota, Ioana Madalina, et al.
Publicado: (2022)

Cardiovascular Involvement in Tuberculosis: From Pathophysiology to Diagnosis and Complications—A Narrative Review
por: Marcu, Dragos Traian Marius, et al.
Publicado: (2023)

Gender Differences and Amputation Risk in Peripheral Artery Disease—A Single-Center Experience
por: Onofrei, Viviana, et al.
Publicado: (2023)

What we know so far
Publicado: (2021)

Short-Term CPAP Improves Biventricular Function in Patients with Moderate-Severe OSA and Cardiometabolic Comorbidities
por: Zota, Ioana Mădălina, et al.
Publicado: (2021)

Infective Endocarditis during Pregnancy—Keep It Safe and Simple!
por: Onofrei, Viviana Aursulesei, et al.
Publicado: (2023)

Omalizumab for successful chemotherapy desensitisation: What we know so far
por: Bumbacea, Roxana Silvia, et al.
Publicado: (2021)

Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)

Vitamin D and Temporomandibular Disorders: What Do We Know So Far?
por: Kui, Andreea, et al.
Publicado: (2021)

Autoimmune pancreatitis: What we know so far
por: Masood, Muaaz
Publicado: (2021)

Incremental Hemodialysis: What We Know so Far
por: Soi, Vivek, et al.
Publicado: (2022)

Monkeypox transmission—what we know so far
por: Venkatesan, Priya
Publicado: (2022)

Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022)

Moebius Syndrome: What We Know So Far
por: Zaidi, Syed Muhammad Hussain, et al.
Publicado: (2023)

Cardiac Biomarkers in Sports Cardiology
por: Costache, Alexandru-Dan, et al.
Publicado: (2022)

The emotional attentional blink: what we know so far
por: McHugo, Maureen, et al.
Publicado: (2013)

Ketogenic Diet and Epilepsy: What We Know So Far
por: D’Andrea Meira, Isabella, et al.
Publicado: (2019)

Thunderstorm-triggered asthma: what we know so far
por: Harun, Nur-Shirin, et al.
Publicado: (2019)

Diet in the Treatment of Epilepsy: What We Know So Far
por: Verrotti, Alberto, et al.
Publicado: (2020)

Coronavirus advice for associates: what we know so far
por: Goldman, James
Publicado: (2020)

Smoking and COVID-19: What we know so far
por: Shastri, Madhur D., et al.
Publicado: (2021)

COVID-19 and cancer: what we know so far
por: Sidaway, Peter
Publicado: (2020)

Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021)

Cholangiocarcinoma and liver transplantation: What we know so far?
por: Safarpour, Ali Reza, et al.
Publicado: (2021)

Carotid Artery Calcification: What We Know So Far
por: Ahmed, Madeeha, et al.
Publicado: (2021)

Update on omicron variant: What we know so far
por: Choudhary, Gajendra, et al.
Publicado: (2022)

COVID-19 and Myositis: What We Know So Far
por: Saud, Ahmad, et al.
Publicado: (2021)

Eosinophilic Esophagitis—What Do We Know So Far?
por: Wąsik, Jakub, et al.
Publicado: (2023)

HIV and neoplasms: What do we know so far?
por: de Souza, Thais Faria, et al.
Publicado: (2023)

Fibrocartilaginous dysplasia: What do we know so far?
por: Alshalan, Asma, et al.
Publicado: (2023)

SARS-CoV-2 Related Myocarditis: What We Know So Far
por: Mistrulli, Raffaella, et al.
Publicado: (2023)

Acute and Long-Term Consequences of COVID-19 on Arterial Stiffness—A Narrative Review
por: Zota, Ioana Mădălina, et al.
Publicado: (2022)

Artificial Neural Network Models for Accurate Predictions of Fat-Free and Fat Masses, Using Easy-to-Measure Anthropometric Parameters
por: Mitu, Ivona, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cld870jf6j8n4acpcu5tpjk4bs